Fatality in HuidaGene CRISPR Trial Sparks Fresh Safety and Transparency Alarms

By Jason Mast and Brian Yang · STAT News · 2026-08-05

A STAT News investigation reveals a child died during a Chinese clinical trial testing a gene-editing treatment for Duchenne muscular dystrophy. The Shanghai-based firm, HuidaGene, remained silent for over a year regarding the study's outcome despite high-profile leadership exits

A STAT News investigation reveals a child died during a Chinese clinical trial testing a gene-editing treatment for Duchenne muscular dystrophy. The Shanghai-based firm, HuidaGene, remained silent for over a year regarding the study's outcome despite high-profile leadership exits